The ILLUMINATE research studies will evaluate how safe and effective an investigational study medication will be as a possible lupus treatment, when compared with placebo (inactive substance).
We invite you to join us in evaluating an investigational new medication for lupus. Qualified individuals are those who have been diagnosed with systemic lupus erythematosus (SLE) and are 18 years of age or older. Other criteria must be met in order to participate and will be determined at the study site.
Participation in the ILLUMINATE research studies will last approximately one year. During this time, participants will be asked to attend monthly visits at the study site. Participants will receive either the study medication or placebo (inactive substance) to be administered as an injection under the skin every 2 weeks. You may be able to continue taking stable doses of some standard lupus medications that you may already be using to manage your lupus symptoms. At the end of the research study, you will have the opportunity to possibly participate in a 4-year extension study, the ILLUMINATE-X Study.
Qualified participants will receive the study medication and study-related physical examinations at no charge. Compensation for time and study-related travel may also be available.